Uncategorized

Nirmatrelvir/Ritonavir (Paxlovid) Prescribing – Renal Function Dosing Considerations

• Post category: Professional Resources

Time-delay Safes in Community Pharmacies

• Post category: Professional Resources

Ontario Pharmacists Can Now Assess and Treat Minor Ailments

• Post category: Advocacy

Therapeutic Options – Focus on Anxiety and Depression in Children and Adolescents 

• Post category: Professional Resources

Protected: Minor Ailments Prescribing in Pharmacy — Tools, Resources and News

• Post category:  

Nirmatrelvir/Ritonavir (Paxlovid) Prescribing

• Post category: Advocacy

Board Update – September 17, 2022, Board Meeting Summary

• Post category: Governance

Professional Liability Insurance Master Policy

• Post category: Insurance

AMS Prescriber Notification Form

• Post category: Professional Resources

AMS Pharmacist Clinical Tool for Identifying Antimicrobial Therapy Problems

• Post category: Professional Resources

AMS Dispensary Flyer

• Post category: Professional Resources

Ontario Drug Benefit (ODB) Program Therapeutic Notes FAQs

• Post category: Professional Resources

Ontario Pharmacists Association Strategic Plan 2023–2025

• Post category: Membership

The Ontario Pharmacists Association Condemns Acts of Violence Against Pharmacy Professionals

• Post category: News and Publications

Ontario Pharmacists Association Announces New Series that Highlights Pharmacy Professionals’ Role in Combating COVID-19

• Post category: News and Publications